Toulouse, France

Michel Sournac

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • Castres, FR (1992)
  • Dijon, FR (1994)
  • Toulouse, FR (2006 - 2021)

Company Filing History:


Years Active: 1992-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michel Sournac: Innovator in Transdermal Drug Delivery

Introduction

Michel Sournac is a notable inventor based in Toulouse, France. He has made significant contributions to the field of transdermal drug delivery systems. With a total of 5 patents to his name, Sournac's work focuses on innovative solutions for drug administration, particularly in the context of tobacco cessation.

Latest Patents

One of Sournac's latest patents is a transdermal device that includes porous microparticles capable of containing an active principle, specifically nicotine. This invention aims to provide an effective method for drug delivery, particularly for individuals seeking to quit smoking. The patent also details a method for preparing such a transdermal device, emphasizing its potential as a valuable tool in tobacco cessation efforts.

Career Highlights

Throughout his career, Michel Sournac has worked with prominent companies in the pharmaceutical industry, including Pierre Fabre Medicament and Pierre Fabre Médicament. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug delivery systems.

Collaborations

Sournac has collaborated with various professionals in his field, including Joel Bougaret and Isabel Ribeiro Dos Santos. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Michel Sournac's contributions to transdermal drug delivery highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to influence the field and offers promising avenues for future research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…